1. What Is the Affinity Chromatography Market?
The Affinity Chromatography Market encompasses liquid chromatography systems, resins, columns, and consumables that separate and purify biomolecules by exploiting specific reversible biological interactions between a target molecule and an immobilised ligand on the chromatography matrix. The market includes Protein A resin columns for monoclonal antibody capture and ion metal affinity chromatography for recombinant protein purification. It also includes immunoaffinity columns for clinical diagnostic analyte enrichment and heparin affinity resins for growth factor and coagulation factor purification. These products are used by pharmaceutical manufacturers during monoclonal antibody and recombinant protein downstream processing, by researchers for protein purification in academic and discovery laboratories, and by diagnostic manufacturers for analyte enrichment in assay preparation. Market scope covers affinity chromatography resins, pre-packed columns, and affinity-based HPLC and FPLC system configurations for biopharmaceutical manufacturing and laboratory applications. It excludes non-affinity ion exchange, size exclusion, and reverse phase chromatography modes, and general analytical HPLC for small molecule separations.
2. Affinity Chromatography Market Size & Forecast
3. Emerging Technologies
- Alkaline-stable Protein A ligand engineering is advancing recombinant Protein A variant ligands with improved resistance to 0_5M and 1_0M sodium hydroxide CIP conditions, reducing ligand leaching and extending Protein A column lifetime by enabling. Growing industry adoption of this technology is motivating development.
- High-capacity Protein A resin development is advancing supermacroporous agarose and polyhydroxyethylmethacrylate bead matrices with dynamic binding capacities exceeding 70 mg IgG per ml resin, enabling smaller column footprints and shorter cycle times for high-titre. Growing industry adoption of this technology is motivating development.
- Multi-attribute method affinity purification is advancing integrated Protein A capture and peptide mapping workflows that enable simultaneous mAb purity assessment, host cell protein depletion monitoring, and post-translational modification analysis. Growing industry adoption of this technology is motivating development.
- AAV gene therapy affinity chromatography is advancing capsid-specific affinity ligands for AAV serotype-selective purification that replace ultracentrifugation as the primary AAV vector capture step, improving yield and reducing manufacturing cost. Growing industry adoption of this technology is motivating development.
Similar technologies are also transforming adjacent markets. Learn more in our Continuous Chromatography Market.
4. Key Market Opportunity
A major opportunity in the Affinity Chromatography Market is the development of novel affinity capture ligands and resins for emerging biopharmaceutical modalities including bispecific antibodies, antibody-drug conjugates, and gene therapy viral vectors that require selective purification beyond what is achievable with conventional Protein A. A significant proportion of advanced biopharmaceutical products including bispecific antibodies, non-IgG scaffolds, and viral vectors require purification from complex biological matrices that cannot be addressed by conventional Protein A capture, creating demand for new affinity ligands with different selectivities. Growing biopharmaceutical pipeline complexity and the increase in non-standard antibody formats and gene therapy vectors requiring novel capture ligands are driving affinity chromatography product innovation beyond conventional Protein A and IMAC technologies. Affinity chromatography developers that commercialise novel capture ligands validated for bispecific antibody, ADC, and AAV vector purification with GMP-compatible resin formats and regulatory submission packages are positioned to capture growing demand from advanced biopharmaceutical manufacturing.
5. Top Companies in the Affinity Chromatography Market
The following organisations hold leading positions in the Affinity Chromatography Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Cytiva (GE Healthcare)
- Thermo Fisher Scientific
- Repligen
- Sartorius
- Merck Millipore
- Bio-Rad Laboratories
- Purolite
- Kaneka
- Tosoh Bioscience
- JSR Life Sciences
6. Market Segmentation
The Affinity Chromatography Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Ligand Type | Protein A Affinity Protein G Affinity Protein G Immunoglobulin IMAC Metal Affinity Ni-NTA His-Tag Resin Heparin Affinity Heparin Agarose Resin Lectin Affinity ConA Glycoprotein Streptavidin Biotin Streptavidin Agarose Dye Ligand Affinity Cibacron Blue Albumin |
| By Application | Monoclonal Antibody Purification Capture Step mAb Polishing Step mAb Recombinant Protein His-Tag Protein Purification GST-Tagged Protein Plasma Protein Fractionation Coagulation Factor Purification Immunoglobulin Plasma Research Purification Laboratory Scale Protein Gene Therapy Purification Viral Vector AAV Purification |
| By Scale | Process Scale Axial Flow Column GMP Single-Use Bioprocess Column Lab Scale FPLC Research Column Micro-Scale Spin Column |
| By End User | Biopharmaceutical Manufacturers Commercial mAb Manufacturing Biosimilar Manufacturers Academic Research Protein Biochemistry Research Contract Research and Manufacturing CDMO Downstream Purification |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Affinity Chromatography Market trajectory over the forecast period:
Protein A Affinity Capture Technology Remains the Gold Standard First-Step Purification for All FDA and EMA-Approved Monoclonal Antibody Products, biopharmaceutical process development scientists.Downstream processing engineers specifying mAb purification platform technology continue selecting Protein A affinity capture as the mandatory first purification step as its IgG selectivity achieves greater than 99 percent purity in a single chromatographic operation. Cytiva continued commercial development of the MabSelect PrismA Protein A resin with high capacity. Alkaline stability for CIP in 2024, maintaining market leadership in Protein A affinity capture resin supply for commercial monoclonal antibody manufacturing at global biopharmaceutical facilities.
Single-Use Pre-Packed Affinity Column Technology Is Reducing Cleaning Validation Burden and Accelerating Process Development Timelines.Biopharmaceutical process development teams are adopting single-use pre-packed Protein A and IMAC affinity columns that eliminate column packing validation, cleaning validation, resin reuse qualification activities. This accelerates the development timeline from cell culture to GMP clinical supply. Cytiva, Thermo Fisher Scientific, and Repligen continued commercial development of single-use pre-packed affinity column portfolios in 2024, providing process development and clinical manufacturing teams with validated ready-to-use columns for mAb capture and recombinant protein purification.
IMAC His-Tag Purification Technology Is Enabling Rapid One-Step Recombinant Protein Capture for Research and Process Development Applications.Protein biochemistry researchers and process development scientists producing hexahistidine-tagged recombinant proteins for structural biology, assay development, and investigational drug production are using IMAC Ni-NTA. Cobalt resin columns as the rapid single-step capture method for His-tagged fusion proteins from cleared lysate. Qiagen continued commercial development and application expansion of Ni-NTA agarose and nickel sepharose IMAC resin products in 2024. This provides academic and pharmaceutical research laboratories with validated IMAC resin formats from micro-scale spin columns to process scale slurry.
For related market intelligence, see the Size Exclusion Chromatography Market.
8. Segmental Analysis
By ligand type, Protein A affinity dominated the Affinity Chromatography Market in 2025, driven by the universal Protein A capture requirement in all IgG monoclonal antibody purification platforms and the large commercial mAb manufacturing base. Biopharmaceutical downstream processing teams continue specifying Protein A affinity capture as the mandatory first step for all IgG mAb products as its IgG selectivity achieves greater than 99 percent purity in a single chromatographic step. IMAC metal affinity is the fastest-growing ligand type, driven by growing recombinant protein production in pharmaceutical research requiring His-tag purification and expanding gene therapy adoption of IMAC for viral vector component purification. Protein biochemists and process development scientists are increasing IMAC resin adoption as His-tag recombinant protein production volumes expand in structural biology, assay development, and investigational programmes requiring rapid one-step capture.
By application, monoclonal antibody purification dominated the Affinity Chromatography Market in 2025, driven by the large commercial mAb manufacturing sector generating high-volume Protein A resin consumption for IgG capture in every approved antibody product. Biopharmaceutical manufacturers continue generating the highest affinity chromatography revenue as every commercial mAb product and biosimilar programme requires validated Protein A resin capture consuming multi-kilogram volumes per manufacturing campaign. Gene therapy purification is the fastest-growing application, driven by growing AAV and lentiviral vector manufacturing demand for affinity chromatography-based capsid capture replacing ultracentrifugation as the primary gene therapy purification platform. Gene therapy CDMOs and manufacturers are increasing affinity chromatography adoption for viral vector purification as capsid-specific affinity ligands provide scalable GMP-compatible capture column formats with improved yield and purity over centrifugation-based vector enrichment.
9. Regional Analysis
Regional demand patterns across the Affinity Chromatography Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Affinity Chromatography Market in 2025, with a market share of 40.0%. The region's leadership reflects the large United States biopharmaceutical manufacturing base generating the highest global monoclonal antibody Protein A resin consumption, the concentration of major chromatography technology developers with North American commercial headquarters, and the large academic and pharmaceutical research protein purification market in the United States. The large United States commercial monoclonal antibody manufacturing sector generates consistent high-volume Protein A affinity resin demand as every FDA-approved mAb product requires Protein A capture in its validated downstream purification platform. Growing United States gene therapy and advanced biotherapeutic manufacturing investment is expanding the affinity chromatography market beyond conventional mAb purification to include AAV vector capture ligand and novel affinity resin demand at gene therapy CDMOs and manufacturers.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 11.30% during the forecast period. Growing monoclonal antibody biosimilar manufacturing in China and South Korea, expanding biopharmaceutical CDMO sector development in China and India, and increasing academic life sciences research investment across the region are creating demand for Protein A resins, IMAC columns, and other affinity purification consumables. Growing Chinese biosimilar mAb manufacturing capacity at domestic biopharmaceutical manufacturers is creating large-volume Protein A affinity resin demand as Chinese biosimilar programmes establish domestic downstream purification processes requiring Protein A capture step validation. Growing South Korean and Japanese biopharmaceutical CDMO sector expansion and government investment in advanced biologics manufacturing capability are increasing affinity chromatography resin and column consumption at Asia Pacific biopharmaceutical contract manufacturing organisations.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Affinity Chromatography Market was valued at USD 3.91 Bn in 2025 and is projected to reach USD 8.29 Bn by 2034, growing at a CAGR of 8.70% over the 2026–2034 forecast period.
The Affinity Chromatography Market is projected to grow at a CAGR of 8.70% from 2026 to 2034.
North America dominated the Affinity Chromatography Market in 2025, with a market share of 40.0%.
The leading companies in the Affinity Chromatography Market include Cytiva (GE Healthcare), Thermo Fisher Scientific, Repligen, Sartorius, Merck Millipore, Bio-Rad Laboratories, Purolite, Kaneka, Tosoh Bioscience, JSR Life Sciences.
Protein a affinity capture technology remains the gold standard first-step purification for all fda and ema-approved monoclonal antibody products, biopharmaceutical process development scientists.
By ligand type, Protein A affinity dominated the Affinity Chromatography Market in 2025, driven by the universal Protein A capture requirement in all IgG monoclonal antibody purification platforms and the large commercial mAb manufacturing base.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.